Antibodies against the measles matrix polypeptide after clinical infection and vaccination

Carolyn E. Machamer; Edward C. Hayes; Susan D. Gollobin; Linda K. Westfall; Hans J. Zweerink

doi:10.1128/iai.27.3.817-825.1980

Antibodies against the measles matrix polypeptide after clinical infection and vaccination

Carolyn E. Machamer, Edward C. Hayes, Susan D. Gollobin, Linda K. Westfall, Hans J. Zweerink

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Sera from patients exposed to measles virus were investigated for the presence of antibodies against each of the viral antigens. All sera with measurable neutralizing titers contained antibodies against the two surface proteins (the glycoprotein and fusion protein), the nucleocapsid protein, and one of the internal proteins infection (natural measles and atypical measles) contained antibodies against the measles virus matrix protein. Levels of matrix-specific antibodies were highest in patients with atypical measles infection.

Original language	English (US)
Pages (from-to)	817-825
Number of pages	9
Journal	Infection and immunity
Volume	27
Issue number	3
DOIs	https://doi.org/10.1128/iai.27.3.817-825.1980
State	Published - 1980
Externally published	Yes

ASJC Scopus subject areas

Parasitology
Microbiology
Immunology
Infectious Diseases

Access to Document

10.1128/iai.27.3.817-825.1980

Cite this

@article{06a5458ae5074666b9f016163726e524,

title = "Antibodies against the measles matrix polypeptide after clinical infection and vaccination",

abstract = "Sera from patients exposed to measles virus were investigated for the presence of antibodies against each of the viral antigens. All sera with measurable neutralizing titers contained antibodies against the two surface proteins (the glycoprotein and fusion protein), the nucleocapsid protein, and one of the internal proteins infection (natural measles and atypical measles) contained antibodies against the measles virus matrix protein. Levels of matrix-specific antibodies were highest in patients with atypical measles infection.",

author = "Machamer, {Carolyn E.} and Hayes, {Edward C.} and Gollobin, {Susan D.} and Westfall, {Linda K.} and Zweerink, {Hans J.}",

year = "1980",

doi = "10.1128/iai.27.3.817-825.1980",

language = "English (US)",

volume = "27",

pages = "817--825",

journal = "Infection and immunity",

issn = "0019-9567",

publisher = "American Society for Microbiology",

number = "3",

}

TY - JOUR

T1 - Antibodies against the measles matrix polypeptide after clinical infection and vaccination

AU - Machamer, Carolyn E.

AU - Hayes, Edward C.

AU - Gollobin, Susan D.

AU - Westfall, Linda K.

AU - Zweerink, Hans J.

PY - 1980

Y1 - 1980

N2 - Sera from patients exposed to measles virus were investigated for the presence of antibodies against each of the viral antigens. All sera with measurable neutralizing titers contained antibodies against the two surface proteins (the glycoprotein and fusion protein), the nucleocapsid protein, and one of the internal proteins infection (natural measles and atypical measles) contained antibodies against the measles virus matrix protein. Levels of matrix-specific antibodies were highest in patients with atypical measles infection.

AB - Sera from patients exposed to measles virus were investigated for the presence of antibodies against each of the viral antigens. All sera with measurable neutralizing titers contained antibodies against the two surface proteins (the glycoprotein and fusion protein), the nucleocapsid protein, and one of the internal proteins infection (natural measles and atypical measles) contained antibodies against the measles virus matrix protein. Levels of matrix-specific antibodies were highest in patients with atypical measles infection.

UR - http://www.scopus.com/inward/record.url?scp=0018865254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018865254&partnerID=8YFLogxK

U2 - 10.1128/iai.27.3.817-825.1980

DO - 10.1128/iai.27.3.817-825.1980

M3 - Article

C2 - 7380553

AN - SCOPUS:0018865254

SN - 0019-9567

VL - 27

SP - 817

EP - 825

JO - Infection and immunity

JF - Infection and immunity

IS - 3

ER -

Antibodies against the measles matrix polypeptide after clinical infection and vaccination

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this